| Literature DB >> 36157044 |
Omar Dheyauldeen Salahdin1, Indrajit Patra2, Mohammad Javed Ansari3, Samar Emad Izzat4, Khusniddin Fakhriddinovich Uktamov5, Mohammed Kadhem Abid6, Ahmed B Mahdi7, Ali Thaeer Hammid8, Yasser Fakri Mustafa9, Himanshu Sharma10.
Abstract
Efficient cobalt-metal organic framework (Co-MOF) was prepared via a controllable microwave-assisted reverse micelle synthesis route. The products were characterized by SEM image, N2 adsorption/desorption isotherm, FTIR spectrum, and TG analysis. Results showed that the products have small particle size distribution, homogenous morphology, significant surface area, and high thermal stability. The physicochemical properties of the final products were remarkable compared with other MOF samples. The newly synthesized nanostructures were used as recyclable catalysts in the synthesis of 1,4-dihydropyridine derivatives. After the confirmation of related structures, the antioxidant activity of derivatives based on the DPPH method was evaluated and the relationship between structures and antioxidant activity was observed. In addition to recyclability, the catalytic activity of Co-MOF studied in this research has remarkable effects on the synthesis of 1,4 dihydropyridine derivatives.Entities:
Keywords: DPPH method; antioxidant activity; catalytic activity; cobalt–metal organic framework; dihydropyridine
Year: 2022 PMID: 36157044 PMCID: PMC9493035 DOI: 10.3389/fchem.2022.932902
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.545
FIGURE 1Structure of Alzheimer’s disease drugs contain 1,4-dihydropyridine.
FIGURE 2Thermal curve (A), SEM image (B), N2 adsorption/desorption behaviour (C) and XRD patterns of Co-MOF nanostructures synthesized by microwave assisted reverse micelle route (D).
Thermal results of the Co-MOF samples synthesized by microwave assisted reverse micelle route.
| Steps. No | Temperature (°C) | Probable composition of grp. Lost |
|---|---|---|
| I | 76 | Vanishing the adsorbed solvent |
| II | 109 | Evaporation of the trapped solvent |
| III | 390 | Micelle disintegration |
| IV | 445 | Ligand (linker) decomposition |
| V | 522 | Final decomposition |
FIGURE 3FTIR spectrum of Co-MOF nanostructures synthesized by microwave assisted reverse micelle route.
FIGURE 4Suggested formula for Co-MOF nanostructures synthesized by microwave assisted reverse micelle route.
SCHEME 1Synthesis 1,4-dihydropyridine derivative by Co-MOF nanostructures.
Optimization conditions (solvent, amount of catalyst and temperature) in synthesis of 5a..
| No | Product | Solvent | Amount of catalyst (mg) | Temperature (oC) | Time (min) | Yield (%) |
|---|---|---|---|---|---|---|
| 1 | 5a | H2O | 1 | 50 | 60 | 36 |
| 2 | 5a | H2O:EtOH (1:1) | 1 | 50 | 60 | 54 |
| 3 | 5a | EtOH | 1 | 50 | 20 | 83 |
| 5 | 5a | MeOH | 1 | 50 | 60 | 31 |
| 6 | 5a | CH3CN | 1 | 50 | 60 | N. R |
| 7 | 5a | EtOH | 2 | 50 | 20 | 88 |
| 8 | 5a | EtOH | 3 | 50 | 15 | 92 |
| 9 | 5a | EtOH | 4 | 50 | 15 | 91 |
| 10 | 5a | EtOH | 5 | 50 | 15 | 90 |
| 11 | 5a | EtOH | 3 | r. T | 60 | 42 |
| 12 | 5a | EtOH | 3 | 40 | 30 | 71 |
|
|
|
|
|
| 8 |
|
| 14 | 5a | EtOH | 3 | reflux | 10 | 92 |
Ethanol, 60°C and 3 mg of Co-MOF nanostructures were obtained as the optimal solvent, temperature and amount of catalyst, conditions for synthesis 5a. In optimizing the amount of the catalyst, the amounts of 1, 2, 3, 4, and 5 mg of the catalyst were examined and the results showed that the amounts of 3, 4 and 5 mg give the highest efficiency and their results were slightly different. Therefore, the amount of 3 mg of catalyst was chosen as the optimal amount of catalyst.
Synthesis of 1,4-dihydropyridine derivatives (5a–h).
| Entry | Product | R2 | Structure | Time (min) | Yield (%) | Mp (°C) | |
|---|---|---|---|---|---|---|---|
| Found | Reported | ||||||
| 1 | 5a | Me |
| 8 | 95 | 257–259 | 256–258 |
| 2 | 5b | Me |
| 30 | 72 | 215–217 | New |
| 3 | 5c | Me |
| 36 | 87 | 220–222 | New |
| 4 | 5d | Me |
| 25 | 83 | 235–237 | New |
| 5 | 5e | Et |
| 10 | 93 | 258–260 | 255–257 |
| 6 | 5f | Et |
| 25 | 75 | 217–219 | 220–223 |
| 7 | 5g | Et |
| 45 | 91 | 227–228 | 226–228 |
| 8 | 5h | Et |
| 20 | 86 | 241–243 | 243–245 |
SCHEME 2Proposed mechanism for the synthesis 1,4-dihydropyridine derivative by Co-MOF nanostructures.
FIGURE 5Reusability of Co-MOF nanostructures in synthesis 1,4-dihydropyridine derivatives.
Comparison of different catalysts in the synthesis methyl 4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (5a).
| Entry | Cat | Time (min) | Temperature (°C) | Yield (%) |
|---|---|---|---|---|
| 1 | Mo@GAA-Fe3O4MNPs (10 mg) | 15 | 90 | 95 |
| 2 | BiFeO3 (5 mg) | 3 | 100 | 93 |
| 3 | Ti@PMO‐IL (0.2 mol%) | 26 | 60 | 93 |
| 4 | Nickel containing ionic liquid (0.5 mol%) | 15 | 70 | 95 |
| 5 | Co. MOF (3 mg) (this word) | 8 | 60 | 95 |
The results were evaluated with ascorbic acid based on our previous reports (Moghaddam-Manesh et al., 2019).
Antioxidant activities of 1,4-dihydropyridine derivatives (5a–h).
| Derivatives | (%) Scavenging concentrations (μg/ml) | IC50 (μg/ml) | |||
|---|---|---|---|---|---|
| 5 | 10 | 15 | 20 | ||
| 5a | 45 | 49 | 55 | 64 | 12.68 |
| 5b | 46 | 49 | 52 | 57 | 13.83 |
| 5c | 43 | 47 | 56 | 59 | 13.43 |
| 5d | 40 | 43 | 55 | 59 | 13.98 |
| 5e | 42 | 48 | 55 | 59 | 12.75 |
| 5f | 39 | 43 | 51 | 56 | 14.91 |
| 5g | 39 | 42 | 53 | 58 | 14.46 |
| 5h | 41 | 45 | 54 | 58 | 14.03 |
| Ascorbic acid | 87.5 | 92.25 | 97.08 | 98.98 | 3.94 |
FIGURE 6Proposed mechanism for radical stability of DPPH by 1,4-dihydropyridine derivatives.